Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Zeria updates status of GI pipeline

April 25, 2000

ID Biomedical licenses oral E. coli vaccine technology

April 25, 2000

New controlled-release, microencapsulated HBV vaccine prepared in China

April 24, 2000

NIH research sheds light on chronic hepatitis C

April 24, 2000

Glaxo Wellcome obtains nonexclusive HCV license from Chiron

April 20, 2000

Adefovir dipivoxil shows activity against lamivudine-resistant HBV

April 20, 2000

Dainippon describes motility-enhancing activity of 5-HT4 receptor agonists

April 18, 2000

Isis Pharmaceuticals completes financing with Elan for HCV joint venture

April 18, 2000

Kosan Biosciences awarded SBIR grant to develop motilin receptor agonists

April 18, 2000

Maxamine plus IFN-alpha yields up to 69% complete response in HCV

April 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...